You just read:

CureLab Oncology, Inc. Publishes Results of Phase I/IIa Clinical Trials of Its Anti-Cancer DNA Vaccine, Elenagen™

News provided by

CureLab Oncology, Inc.

Mar 28, 2017, 08:00 ET